Nutricircle Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve IN ADDITION TO BOARD MEETING INTIMATION ....
Awaiting price reaction for this filing.
Nutricircle Ltd has informed BSE that its Board of Directors will meet on 13 February 2026 at 3:00 p.m. to consider and approve the Un-Audited Standalone Financial Results for the quarter and nine months ended 31 December 2025, along with the Limited Review Report. Additionally, the Board will consider the allotment/conversion of convertible warrants into Equity Shares of Rs. 10 each at an issue price of Rs. 10 each on a preferential basis to the Promoter & Director, following a special resolution passed at the EGM on 24 September 2024 and the in-principle approval from BSE dated 24 December 2024. This is an additional intimation supplementing the earlier notice dated 3 February 2026. Any other business with the Chair's permission may also be taken up.
Investors should watch for the Q3 FY26 results announcement, which could influence short-term stock movement. The conversion of warrants into equity shares at the same price (Rs. 10) as the warrant issue price means no fresh capital inflow for the company, but it increases the promoter's shareholding, signalling promoter confidence while also resulting in equity dilution for existing shareholders.